CRP

Across TCGA pan-cancer cohorts, CRP mass-spec protein differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of CRP’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where CRP mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types CRP is over-expressed in tumor, although a few such as HNSC show the opposite, repressed pattern.

HNSC, CCRCC, and LUAD are the cancer types where CRP tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CRP mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	II,III,IV	−0.987	.007	5	view →
CCRCC	Male	All	+0.333	.041	2	view →
LUAD	All	II,III,IV	+0.335	<.001	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

CRP–HNSC

Open the HNSC breakdown →